Quantitative structure–activity analysis of 5-arylidene-2,4-thiazolidinediones as aldose reductase inhibitors
- 1 February 2006
- journal article
- research article
- Published by Elsevier BV in Bioorganic & Medicinal Chemistry Letters
- Vol. 16 (3), 512-520
- https://doi.org/10.1016/j.bmcl.2005.10.069
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Structure–activity relationships and molecular modelling of 5-arylidene-2,4-thiazolidinediones active as aldose reductase inhibitorsBioorganic & Medicinal Chemistry, 2005
- Molecular Modeling and Structure-based Drug Discovery Studies of Aldose Reductase InhibitorsChem-Bio Informatics Journal, 2002
- Diabetes complications and their potential prevention: Aldose reductase inhibition and other approachesMedicinal Research Reviews, 1999
- A Meta-analysis of Trials on Aldose Reductase Inhibitors in Diabetic Peripheral NeuropathyDiabetic Medicine, 1996
- Prevention and Treatment of the Complications of Diabetes MellitusThe New England Journal of Medicine, 1995
- The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes MellitusThe New England Journal of Medicine, 1993
- Long-Term Complications of Diabetes MellitusThe New England Journal of Medicine, 1993
- The role of aldose reductase in the development of diabetic complicationsMedicinal Research Reviews, 1988
- The involvement of aldose reductase in diabetic complicationsDiabetes/Metabolism Research and Reviews, 1988
- Aldose reductase inhibitors: a potential new class of agents for the pharmacological control of certain diabetic complicationsJournal of Medicinal Chemistry, 1985